Trial Profile
This prospective, non-interventional, observational study to evaluate the efficacy and safety of paliperidone palmitate long-acting injection in patients with Schizophrenia.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Dec 2015
Price :
$35
*
At a glance
- Drugs Paliperidone (Primary)
- Indications Schizophrenia
- Focus Adverse reactions; Therapeutic Use
- 14 Dec 2015 New trial record